Expert Opinion on Drug Safety, Volume 15, Issue 10 (2016)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Safety, Volume 15, Issue 10 (2016)

See all volumes and issues
Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Volume 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Editorial

Editorial
Monoclonal antibodies for treating multiple myeloma - a new era, new safety considerations?
Stefania Oliva & Antonio Palumbo
Pages: 1295-1300
Published online: 05 Jul 2016
First Page PreviewforMonoclonal antibodies for treating multiple myeloma - a new era, new safety considerations? | Full Text | References | PDF (521.8 KB)
  • 1823 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Original Research

Article
Testing the usefulness of the number needed to treat to be harmed (NNTH) in benefit-risk evaluations: case study with medicines withdrawn from the European market due to safety reasons
Diogo Mendes, Carlos Alves & Francisco Batel Marques
Pages: 1301-1312
Published online: 05 Aug 2016
AbstractforTesting the usefulness of the number needed to treat to be harmed (NNTH) in benefit-risk evaluations: case study with medicines withdrawn from the European market due to safety reasons | Full Text | References | PDF (985.9 KB) | Supplemental
  • 240 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Benzodiazepine dependence in subjects with alcohol use disorders: what prevalence?
A. Morel, M. Grall-Bronnec, S. Bulteau, P. Chauvin-Grelier, L. Gailledrat, M. L. Pinot, P. Jolliet & C. Victorri-Vigneau
Pages: 1313-1319
Published online: 22 Aug 2016
AbstractforBenzodiazepine dependence in subjects with alcohol use disorders: what prevalence? | Full Text | References | PDF (734.1 KB)
  • 253 Views
  • 13 CrossRef citations
  • 0Altmetric
Article
Systematic review of paediatric studies of adverse drug reactions from pharmacovigilance databases
Kennedy Obebi Cliff-Eribo, Helen Sammons & Imti Choonara
Pages: 1321-1328
Published online: 22 Aug 2016
AbstractforSystematic review of paediatric studies of adverse drug reactions from pharmacovigilance databases | Full Text | References | PDF (601.2 KB)
  • 505 Views
  • 32 CrossRef citations
  • 0Altmetric

Review

Review
An update of safety of clinically used atypical antipsychotics
L. Orsolini, C. Tomasetti, A. Valchera, R. Vecchiotti, I. Matarazzo, F. Vellante, F. Iasevoli, E. F. Buonaguro, M. Fornaro, A. L. C. Fiengo, G. Martinotti, M. Mazza, G. Perna, A. Carano, A. De Bartolomeis, M. Di Giannantonio & D. De Berardis
Pages: 1329-1347
Published online: 04 Jul 2016
AbstractforAn update of safety of clinically used atypical antipsychotics | Full Text | References | PDF (1.3 MB)
  • 1926 Views
  • 99 CrossRef citations
  • 0Altmetric
Review
Switching antiretroviral regimes for the treatment of HIV: safety implications
Laia Utrillo, Francesc Vidal, Teresa Puig & Pere Domingo
Pages: 1349-1360
Published online: 08 Jul 2016
AbstractforSwitching antiretroviral regimes for the treatment of HIV: safety implications | Full Text | References | PDF (949 KB) | Supplemental
  • 325 Views
  • 3 CrossRef citations
  • 0Altmetric
Review
Prophylaxis of vertical HBV infection
Malgorzata Pawlowska, Anna Pniewska, Malgorzata Pilarczyk, Dorota Kozielewicz & Krzysztof Domagalski
Pages: 1361-1368
Published online: 21 Jul 2016
AbstractforProphylaxis of vertical HBV infection | Full Text | References | PDF (760.1 KB)
  • 549 Views
  • 9 CrossRef citations
  • 0Altmetric
Review
Adverse effects of oral second-line antituberculosis drugs in children
H. Simon Schaaf, Stephanie Thee, Louvina van der Laan, Anneke C. Hesseling & Anthony J. Garcia-Prats
Pages: 1369-1381
Published online: 05 Aug 2016
AbstractforAdverse effects of oral second-line antituberculosis drugs in children | Full Text | References | PDF (959.1 KB)
  • 398 Views
  • 24 CrossRef citations
  • 0Altmetric
Review
The safety of treatment options for pediatric Crohn’s disease
Victoria Grossi & Jeffrey S. Hyams
Pages: 1383-1390
Published online: 01 Jul 2016
AbstractforThe safety of treatment options for pediatric Crohn’s disease | Full Text | References | PDF (637.3 KB)
  • 474 Views
  • 7 CrossRef citations
  • 0Altmetric
Review
The safety of pharmacologic options for the treatment of persons with hemophilia
Massimo Franchini & Pier Mannuccio Mannucci
Pages: 1391-1400
Published online: 18 Jul 2016
AbstractforThe safety of pharmacologic options for the treatment of persons with hemophilia | Full Text | References | PDF (740 KB)
  • 553 Views
  • 9 CrossRef citations
  • 0Altmetric
Review
Update review of the safety of sodium-glucose cotransporter 2 inhibitors for the treatment of patients with type 2 diabetes mellitus
Curt J. Carlson & Marile L. Santamarina
Pages: 1401-1412
Published online: 12 Aug 2016
AbstractforUpdate review of the safety of sodium-glucose cotransporter 2 inhibitors for the treatment of patients with type 2 diabetes mellitus | Full Text | References | PDF (895.4 KB)
  • 1866 Views
  • 26 CrossRef citations
  • 0Altmetric

Drug Safety Evaluation

Article
Safety of secukinumab in the treatment of psoriasis
Andrew Blauvelt
Pages: 1413-1420
Published online: 22 Aug 2016
AbstractforSafety of secukinumab in the treatment of psoriasis | Full Text | References | PDF (634.4 KB)
  • 17898 Views
  • 86 CrossRef citations
  • 0Altmetric
Free Access
Article
Peginesatide for the treatment of anemia due to chronic kidney disease – an unfulfilled promise
Terhi Hermanson, Charles L. Bennett & Iain C. Macdougall
Pages: 1421-1426
Published online: 23 Aug 2016
AbstractforPeginesatide for the treatment of anemia due to chronic kidney disease – an unfulfilled promise | Full Text | References | PDF (490.2 KB)
  • 309 Views
  • 32 CrossRef citations
  • 0Altmetric
Article
Safety profile of methotrexate in inflammatory bowel disease
Tommaso Gabbani, Simona Deiana, Sarah Lunardi, Natalia Manetti & Vito Annese
Pages: 1427-1437
Published online: 08 Aug 2016
AbstractforSafety profile of methotrexate in inflammatory bowel disease | Full Text | References | PDF (842.9 KB)
  • 415 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
Rupatadine: global safety evaluation in allergic rhinitis and urticaria
Vanesa González-Núñez, Claus Bachert & Joaquim Mullol
Pages: 1439-1448
Published online: 19 Aug 2016
AbstractforRupatadine: global safety evaluation in allergic rhinitis and urticaria | Full Text | References | PDF (1.1 MB)
  • 616 Views
  • 20 CrossRef citations
  • 0Altmetric

Letter to the editor

Letter
Letter to the editor
Response to: Russo A, Capogrosso P, La Croce G, et al. Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia. Expert Opin Drug Saf. 2016 Jun;1:1–10.
Salvatore Arena
Page: 1449
Published online: 01 Sep 2016
CitationforLetter to the editor | Full Text | References | PDF (212.4 KB)
  • 665 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Explore articles